E-LIB Suche - Ergebnisse für: Belema, Makonen

1

Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Ba..:

Gillis, Eric P. ; Parcella, Kyle ; Bowsher, Michael...
Journal of Medicinal Chemistry. 66 (2023) 3 - p. 1941-1954 , 2023

Link: https://doi.org/10.1021/..

2

Scaffold modifications to the 4-(4,4-dimethylpiperidinyl) 2..:

Parcella, Kyle ; Patel, Manoj ; Tu, Yong...
Bioorganic & Medicinal Chemistry. 67 (2022) - p. 116833 , 2022

Link: https://doi.org/10.1016/..

3

Discovery and Preclinical Profiling of GSK3839919, a Potent..:

Parcella, Kyle ; Wang, Tao ; Eastman, Kyle...
ACS Medicinal Chemistry Letters. 13 (2022) 6 - p. 972-980 , 2022

Link: https://doi.org/10.1021/..

4

The Discovery and Development of Daclatasvir: An Inhibitor ..:

, In: Topics in Medicinal Chemistry; HCV: The Journey from Discovery to a Cure,

Meanwell, Nicholas A. ; Belema, Makonen - p. 27-55 , 2019

Link: https://doi.org/10.1007/..

5

Development of the Large-Scale Synthesis of Tetrahydropyran..:

Mathur, Arvind ; Wang, Bei ; Smith, Daniel...
The Journal of Organic Chemistry. 82 (2017) 19 - p. 10376-10387 , 2017

Link: https://doi.org/10.1021/..

6

Resensitizing daclatasvir-resistant hepatitis C variants by..:

Sun, Jin-Hua ; O'Boyle II, Donald R. ; Fridell, Robert A....
Nature. 527 (2015) 7577 - p. 245-248 , 2015

Link: https://doi.org/10.1038/..

7

Hepatitis C Virus NS5A Replication Complex Inhibitors: The ..:

Belema, Makonen ; Nguyen, Van N. ; Bachand, Carol...
Journal of Medicinal Chemistry. 57 (2014) 5 - p. 2013-2032 , 2014

Link: https://doi.org/10.1021/..

8

Hepatitis C Virus NS5A Replication Complex Inhibitors. Part..:

Belema, Makonen ; Nguyen, Van N. ; Romine, Jeffrey L....
Journal of Medicinal Chemistry. 57 (2014) 5 - p. 1995-2012 , 2014

Link: https://doi.org/10.1021/..

9

Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus..:

Belema, Makonen ; Meanwell, Nicholas A.
Journal of Medicinal Chemistry. 57 (2014) 12 - p. 5057-5071 , 2014

Link: https://doi.org/10.1021/..

10

Discovery and Development of Hepatitis C Virus NS5A Replica..:

Belema, Makonen ; Lopez, Omar D. ; Bender, John A....
Journal of Medicinal Chemistry. 57 (2014) 5 - p. 1643-1672 , 2014

Link: https://doi.org/10.1021/..

11

Characterizations of HCV NS5A replication complex inhibitor:

O'Boyle II, Donald R. ; Sun, Jin-Hua ; Nower, Peter T....
Virology. 444 (2013) 1-2 - p. 343-354 , 2013

Link: https://doi.org/10.1016/..

12

HCV NS5A replication complex inhibitors. Part 3: discovery ..:

Lopez, Omar D. ; Nguyen, Van N. ; St. Laurent, Denis R....
Bioorganic & Medicinal Chemistry Letters. 23 (2013) 3 - p. 779-784 , 2013

Link: https://doi.org/10.1016/..

13

HCV NS5A replication complex inhibitors. Part 5: Discovery ..:

Belema, Makonen ; Nguyen, Van N. ; St. Laurent, Denis R....
Bioorganic & Medicinal Chemistry Letters. 23 (2013) 15 - p. 4428-4435 , 2013

Link: https://doi.org/10.1016/..

14

HCV NS5A Replication Complex Inhibitors. Part 4.1 Optimizat..:

St. Laurent, Denis R. ; Serrano-Wu, Michael H. ; Belema, Makonen...
Journal of Medicinal Chemistry. 57 (2013) 5 - p. 1976-1994 , 2013

Link: https://doi.org/10.1021/..

15

A scalable synthesis of (1R,3S,5R)-2-(tert-butoxycarbonyl)-..:

Wang, Gan ; James, Clint A. ; Meanwell, Nicholas A...
Tetrahedron Letters. 54 (2013) 49 - p. 6722-6724 , 2013

Link: https://doi.org/10.1016/..